Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: A 1H MR spectroscopy study

Addiction Biology

Volumn 20, Issue 1, 2015, Pages 69-79

  Yang, Shaolin ^a,b   Belcher, Annabelle M ^a   Chefer, Svetlana ^a,c   Vaupel, D Bruce ^a   Schindler, Charles W ^a   Stein, Elliot A ^a   Yang, Yihong ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Abstinence; glutamate; glutamine; magnetic resonance spectroscopy; methamphetamine; rhesus monkey

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; ASPARTIC ACID; CREATINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; METHAMPHETAMINE; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORYLCHOLINE; TAURINE; CENTRAL STIMULANT AGENT;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CINGULATE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; DRUG USE; FEMALE; GLUCOSE BRAIN LEVEL; LONG TERM EXPOSURE; MALE; NEUROCHEMISTRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; RHESUS MONKEY; WITHDRAWAL SYNDROME; ANIMAL; BRAIN; CINGULATE GYRUS; DRUG EFFECTS; LONGITUDINAL STUDY; METABOLISM;

ANIMALS; BRAIN; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; INOSITOL; LONGITUDINAL STUDIES; MACACA MULATTA; METHAMPHETAMINE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PUTAMEN; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84919837555     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12078     Document Type: Article

References (48)

1. Axt KJ, Molliver ME, (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9: 302-313.
2. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW, (2003) Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6: 743-749.
3. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T, (2005) Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 57: 967-974.
4. Chen XH, Iwata A, Nonaka M, Browne KD, Smith DH, (2003) Neurogenesis and glial proliferation persist for at least one year in the subventricular zone following brain trauma in rats. J Neurotrauma 20: 623-631.
5. Cotter D, Mackay D, Landau S, Kerwin R, Everall I, (2001) Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58: 545-553.
6. Eisch AJ, Marshall JF, (1998) Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30: 433-445.
7. Ernst T, Chang L, (2008) Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 3: 165-172.
8. Ernst T, Chang L, Leonido-Yee M, Speck O, (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54: 1344-1349.
9. Gibb JW, Kogan FJ, (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch Pharmacol 310: 185-187.
10. Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, Marson DC, (2008) Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia. Alzheimers Dement 4: 421-427.
11. Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, Iyo M, (2007) Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. Biol Psychiatry 61: 577-581.
12. Hotchkiss AJ, Morgan ME, Gibb JW, (1979) The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci 25: 1373-1378.
13. Kim SJ, Lyoo IK, Hwang J, Chung A, Hoon Sung Y, Kim J, Kwon DH, Chang KH, Renshaw PF, (2006) Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol 9: 221-228.
14. Licata SC, Renshaw PF, (2010) Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci 1187: 148-171.
15. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL, Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W, (2005) Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 58: 770-778.
16. Marshall JF, O'Dell SJ, (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 35: 536-545.
17. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA, (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35428. J Neurosci 18: 8417-8422.
18. Nash JF, Yamamoto BK, (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581: 237-243.
19. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH, (2005) Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 62: 444-452.
20. Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M, Galloway GP, Pfefferbaum A, Spielman DM, Adalsteinsson E, Sullivan EV, (2002) Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Psychiatry Res 116: 43-52.
21. Preston KL, Wagner GC, Schuster CR, Seiden LS, (1985) Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Res 338: 243-248.
22. Provencher SW, (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
23. Reissner KJ, Kalivas PW, (2010) Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol 21: 514-522.
24. Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V, (2004) Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9: 897-899.
25. Sailasuta N, Abulseoud O, Harris KC, Ross BD, (2010b) Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 30: 950-960.
26. Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD, (2010a) Metabolic abnormalities in abstinent methamphetamine dependent subjects. Subst Abuse 4: 9-20.
27. Salo R, Buonocore MH, Leamon M, Natsuaki Y, Waters C, Moore CD, Galloway GP, Nordahl TE, (2011) Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study. Drug Alcoh Depend 113: 133-138.
28. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH, (2007) Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61: 1272-1280.
29. Sandgren N, Stoica P, (2005) Frequency-selective analysis of multichannel magnetic resonance spectroscopy data. Conf Proc IEEE Eng Med Biol Soc 3: 2371-2374.
30. Schindler CW, Gilman JP, Panlilio LV, McCann DJ, Goldberg SR, (2011) Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys. Exp Clin Psychopharmacol 19: 1-10.
31. Schwendt M, Reichel CM, See RE, (2012) Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats. Plos ONE 7: e34299.
32. Seiden LS, (1975) Brain monoamines and behavior. Psychopharmacol Bull 11: 60-61.
33. Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Ashby CR Jr, Takei N, Mori N, (2002) Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study. Neuropsychopharmacology 27: 453-461.
34. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N, (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63: 90-100.
35. Sonsalla PK, Albers DS, Zeevalk GD, (1998) Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism. Amino Acids 14: 69-74.
36. Stephans SE, Yamamoto BK, (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17: 203-209.
37. Stork C, Renshaw PF, (2005) Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10: 900-919.
38. Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR, (2010) Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 75: 1702-1710.
39. Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK, (2007) Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug Alcohol Depend 88: 28-35.
40. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED, (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24: 6028-6036.
41. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N, (2001a) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
42. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J, (2001b) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418.
43. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J, (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151-160.
44. Wang G, Volkow N, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS,. (2004) Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 161: 242-248.
45. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ, (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699-703.
46. Woolverton WL, Ricuarte GA, Forno LS, Seiden LS, (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486: 73-78.
47. Yang S, Hu J, Kou Z, Yang Y, (2008) Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4. Magn Reson Med 59: 236-244.
48. Yang S, Salmeron BJ, Ross TJ, Xi ZX, Stein EA, Yang Y, (2009) Lower glutamate levels in rostral anterior cingulate of chronic cocaine users-a 1H-MRS study using TE-averaged PRESS at 3T with an optimized quantification strategy. Psychiatry Res 174: 171-176.